rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

William Tai-Wei Ho

CEO

Company insider

Files Form 4 as: CEO, IN8bio.

Every Form 4 they filed

In numbers

Trades disclosed
30
Buys
2
Sells
0
Bought
$75K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
29 Jul 2021
Last trade
9 May 2026
Last filed
12 May 2026

Companies traded

Where they are an officer
INAB IN8bioDirector, Officer, 10% owner · Biotechnology · last 9 May 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 May 2026filed 12 May 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—154,500 at $0.00filing
9 May 2026filed 12 May 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—154,500 at $0.00filing
4 Feb 2026filed 6 Feb 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—206,000 at $0.00filing
4 Feb 2026filed 6 Feb 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—206,000 at $0.00filing
22 Dec 2025filed 23 Dec 2025INAB IN8bioBiotechnologySEC FORM 4 Code A$50K36,232 at $1.38filing
1 May 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code D—81,967filing
1 May 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A$15K81,967 at $0.18filing
27 Apr 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code D—81,967filing
27 Apr 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—81,967filing
5 Feb 2025filed 7 Feb 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—912,450 at $0.00filing
19 Dec 2024filed 23 Dec 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—1,188,282 at $0.00filing
4 Oct 2024filed 8 Oct 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code D—81,967filing
4 Oct 2024filed 8 Oct 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—81,967filing
4 Oct 2024filed 8 Oct 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—126,582filing
4 Oct 2024filed 8 Oct 2024INAB IN8bioBiotechnologySEC FORM 4 Code A—126,582filing
4 Sep 2024filed 5 Sep 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
7 Feb 2024filed 8 Feb 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—502,000 at $0.00filing
13 Dec 2023filed 15 Dec 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—81,967filing
13 Dec 2023filed 15 Dec 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—81,967filing
13 Dec 2023filed 15 Dec 2023INAB IN8bioBiotechnologySEC FORM 4 Code A—81,967filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Emily FairbairnDirector · Director at In8bio, filing Form 4 there in the last year
Jeremy R. GraffOfficer · Director at In8bio, filing Form 4 there in the last year
Peter C. BrandtDirector · Director at In8bio, filing Form 4 there in the last year
Lawrence LambEVP and CSO · EVP and CSO at In8bio, filing Form 4 there in the last year
Corinne EpperlyDirector · Director at In8bio, filing Form 4 there in the last year